Pyridam Farma Ownership

PYFA Stock  IDR 260.00  4.00  1.52%   
Pyridam Farma owns a total of 535.08 Million outstanding shares. Pyridam Farma has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Pyridam Farma in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pyridam Farma, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pyridam Farma Tbk. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pyridam Stock Ownership Analysis

About 60.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pyridam Farma Tbk recorded earning per share (EPS) of 514.07. The entity last dividend was issued on the 31st of May 2019. To find out more about Pyridam Farma Tbk contact the company at 62 21 5099 1067 or learn more at https://www.pyfa.co.id.

Pyridam Farma Outstanding Bonds

Pyridam Farma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pyridam Farma Tbk uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pyridam bonds can be classified according to their maturity, which is the date when Pyridam Farma Tbk has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Pyridam Stock

Pyridam Farma financial ratios help investors to determine whether Pyridam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pyridam with respect to the benefits of owning Pyridam Farma security.